ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.54
0.06%
US Tech 100
17,845.20
0.69%
S&P 500
5,246.68
0.48%
US Dollar vs CAD
1.36417
-0.09%
Bitcoin
61,899.62
0.57%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. IceCure Medical Ltd (ICCM)

  7. IceCure Medical Ltd (ICCM) News

ICCM IceCure Medical Ltd

1.15
-0.01 (-0.86%)
May 14 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
IceCure Medical Ltd ICCM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.01 -0.86% 1.15 18:57:22
Open Price Low Price High Price Close Price Previous Close
1.15 1.10 1.1669 1.12 1.16
more quote information »

Recent News

Date Time Source Heading
5/07/202407:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/07/202407:30PRNUSIndependent Study Results in Japan Demonstrate Zero (0%)..
4/15/202407:35PRNUSIceCure Medical Reports Final ICE3 Breast Cancer..
4/03/202407:30PRNUSIceCure Medical Reports Full Year 2023 Financial Results:..
4/03/202406:11IHMARKETNEWSU.S. Futures Dip in Pre-Market, May WTI and June Brent Crude..
4/02/202407:30PRNUSIceCure Submits FDA Regulatory Filing for New XSense™..
3/27/202407:30PRNUSIceCure Medical to Report 2023 Full Year Financial &..
3/19/202407:30PRNUSIceCure Medical Reports Positive Topline Results From ICE3..
3/12/202407:30PRNUSIceCure Receives Notice of Patent Allowance in Japan for a..
3/07/202407:30PRNUSIceCure Medical to Present at 34th Annual Oppenheimer..
3/04/202407:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/04/202407:30PRNUSIceCure's ProSense® a Promising Alternative Treatment for..
2/27/202407:00PRNUSFourth BRIIT Conference in India Features IceCure's..
2/26/202407:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/26/202407:00PRNUSStudy Using IceCure's ProSense® Treatment Results in 100%..
2/15/202407:00PRNUSIceCure's ProSense® to be Featured at Two Upcoming Medical..
1/30/202407:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/30/202407:00PRNUSU.S. FDA Grants IceCure Medical's Appeal: Reopens De Novo..
1/29/202407:00PRNUSIceCure Medical's Breast Cryoablation Gains Prominence in..
1/16/202407:00PRNUSIceCure Medical's ProSense® Featured at Indian Society of..
1/12/202415:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/12/202415:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/12/202415:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/12/202415:05GLOBEIceCure Medical Regains Compliance with Nasdaq Minimum..
1/10/202407:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/10/202407:00PRNUSIceCure Medical CEO Issues Letter to Shareholders & Reports..
1/03/202407:00PRNUSNew Study Reports IceCure's ProSense® Boosts Immune Response..
12/13/202307:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/13/202307:00PRNUSStudy Using IceCure's ProSense® Finds: "Cryoablation Allows..
11/29/202307:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/29/202307:00PRNUSIceCure's ProSense® Deepens Regulatory Approval in India
11/28/202307:00PRNUSIceCure System Successfully Treated Kidney Cancer Tumor with..
11/15/202307:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/15/202307:00PRNUSIceCure Medical Reports Financial Results as of and for the..
11/15/202306:30PRNUSIceCure Medical Files Appeal with U.S. FDA Requesting a..
11/08/202307:00PRNUSIceCure Medical to Report Third Quarter 2023 Financial &..
11/06/202307:00PRNUSSubstantial Evidence-Based Data Currently Being Generated by..
11/03/202315:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/03/202315:00PRNUSIceCure Medical Announces Receipt of Nasdaq Minimum Bid..
10/30/202307:00PRNUSIceCure's ICE3 Trial Results Demonstrating 96.91% Recurrence..
10/25/202307:00PRNUSIndependent Scientific Paper by Doctors Using IceCure's..
10/05/202307:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/05/202307:00PRNUSWomen Deemed Inoperable for Breast Cancer Benefitted from..
10/02/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/02/202307:00PRNUSIndependent Study Validates IceCure's ProSense Cryoablation..
9/22/202307:00PRNUSRenowned Spanish Radiologist Lucía Graña-López to Present..
9/20/202306:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/20/202306:00PRNUSIceCure Medical Receives FDA Response to De Novo..
9/08/202307:00PRNUSIceCure Medical to Join Hands-On Cryoablation Session with..
9/05/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Your Recent History

NASDAQ
ICCM
IceCure Medical
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved